平渊药学院药学· 药物传递· 生物材料· 纳米医药个人简介:      于2012年获得新加坡国立大学(National University of Singapore)博士学位，之后分别在新加坡科学技术局材料工程研究所 (Institute of Materials Research and Engineering，A*STAR)，墨尔本大学 (The University of Melbourne)及南洋理工大学(Nanyang Technological University)从事科研工作。近年来主要从事方向为高分子药物传输系统在肿瘤治疗中的应用，迄今为止在国际SCI 刊物上已发表论文38篇，其中作为第一作者或通讯作者在Nano Letters ACS Nano Advanced Functional Materials Biomaterials Journal of Controlled Release等国际SCI刊物上发表论文20篇，总引用次数2000余次。曾获得包括德意志学术交流中心访问研究奖等奖项，并入选第十三批中组部“千人计划”青年项目。实验室简介:本实验室成立于2017年10月，隶属于浙江大学药物制剂研究所，主要研究方向为生物材料及纳米医学。实验室主要由化学实验室，细胞培养房及洁净操作间组成。配备了常用的中小型研究仪器设备，包括冷冻干燥仪器、离心机、荧光显微镜、酶标仪、荧光素酶测定仪、液质联用仪、PCR仪、超纯水处理器等。目前实验室科研人员由不同背景的博士后研究员，博士研究生及硕士研究生组成，并欢迎具有化学，生物学，药学或医学背景的研究人员加盟本实验室。研究方向与项目:本实验室的主要研究目标是开发具有多功能的药物递送平台技术，来提高药物的治疗效果。通过包括药学，化学，材料学，生物学及医学等交叉学科研究手段，制备具有生物兼容性好的药物载体，实现药物高效递送及有效治疗。本实验室主要有以下研究方向：1.    蛋白质药物递送：研究及开发具有可以稳定蛋白质药物活性，并可有效传递至病灶部位的药物载体材料。2.    基因编辑工具递送：研究可高效传递基因编辑工具（包括核酸和蛋白），高效定点切割基因组特定位点的载体材料。3.    脑靶向药物递送：研究可通透血脑屏障，并可在特定脑区释放药物的递送载体材料。     所负责科研项目：1. 国家“千人计划”青年项目，药剂学2. 浙江大学“百人计划”启动经费3. 中央高校基本科研业务费教学与课程:主讲研究生课程:分子生物药剂学，32学时。研究与成果:代表性研究论文 (*通讯作者；#共同第一作者):1.     Z. Zhang T. Wan Y. Chen Y. Chen H. Sun T. Cao Z. Songyang G. Tang C. Wu Y. Ping* F. J. Xu* J. Huang*. Cationic Polymer‐Mediated CRISPR/Cas9 Plasmid Delivery for Genome Editing. Macromol. Rapid Commun. 2018 1800068.2.     Y. Li H. Bai H. Wang Y. Shen G. Tang* Y. Ping* Reactive Oxygen Species (ROS)-Responsive Nanomedicine for RNAi-Based Cancer Therapy. Nanoscale 2018 10 203-214.3.     H. Wang Y. Li H. Bai J. Shen X. Chen Y. Ping* Guping Tang* A Cooperative Dimensional Strategy for Enhanced Nuclear-Targeted Delivery of Anticancer Drug. Adv. Funct. Mater 2017 27 1700339.4.     Y. Ping D. Ding R. Ramos K. Deepankumar H. Mohanram A. Miserez* Supramolecular β-sheets Stabilized Protein Nanocarriers for Drug Delivery and Gene Transfection. ACS Nano 2017 11 4528-4541.5.     H. Wang# W. Zhu# Y. Ping # C. Wang N. Gao X. Yin C. Gu D. Ding J. Brinker* G. Li* Controlled Fabrication of Functional Capsules Based on the Synergistic Interaction between Polyphenols and MOFs under Weak Basic Condition. ACS Appl. Mater. Interfaces. 2017 9 14258–14264. 6.     M. Wu X. Liu W. Jin Y. Li Y. Li Q. Hu P. Chu G. Tang Y. Ping* Targeting ETS1 with RNAi-based Supramolecular Nanoassemblies for Multidrug-Resistant Breast Cancer Therapy. J. Control. Release 2017 253 110-121.7.     W. Jin Q. Wang M. Wu Y. Li G. Tang* Y. Ping* P. K. Chu* Multiple Regulation of Cancer Multidrug Resistance through Lanthanide-Functionalized Supramolecular Polymeric Nanoparticles. Biomaterials 2017 129 83.8.     H. Wang Y. Li M. Zhang D. Wu Y. Shen G. Tang* Y. Ping* Redox-Activatable ATP-Depleting Micelles with Dual Modulation Characteristics for Multidrug-Resistant Cancer Therapy.  Adv. Healthcare Mater. 2017 DOI: 10.1002/adhm.201601293.9.     X. Liu M. Wu Q. Hu H. Bai S. Zhang Y. Shen  G. Tang* Y. Ping*. A Redox-activated Light-up Nanomicelle for Precise Imaging-guided Cancer Therapy and Real-time Pharmacokinetic Monitoring" ACS Nano 2016 10 11385–11396. 10.  Y. Ping X. Hu Q. Yao Q. Hu S. Amini A. Miserez* G. Tang*. Engineering bioinspired bacteria-adhesive clay nanoparticles with membrane-disruptive property for treatment of Helicobacter pylori infection Nanoscale 2016 8 16486-16498.11.  K. Wang Q. Hu W. Zhu M. Zhao Y. Ping* G. Tang*. Structure-Invertible Nanoparticles for Triggered Co-Delivery of Nucleic Acids and Hydrophobic Drugs for Combination Cancer Therapy Adv. Funct. Mater. 2015 25 5482–5492.12.  Q. Hu M. Wu C. Fang C. Cheng M. Zhao W. Fang P. K. Chu Y. Ping*  G. Tang*. Engineering Nanoparticle-Coated Bacteria as Oral DNA Vaccines for Cancer Immunotherapy Nano Letters 2015 15 2732–2739.13.  Y. Ping J. Guo H. Ejima X. Chen J. J. Richardson H. Sun and F. Caruso*. Assembly of pH-Responsive Capsules Engineered from Metal-Phenolic Networks for Anticancer Drug Delivery Small 2015 11 2032–2036.14.  D. Li Y. Li J. Guo H. Xing Y. Ping* G. Tang*. Synergistic enhancement of lung cancer therapy through nanocarrier-mediated sequential delivery of superantigen and tyrosin kinase inhibitor. Adv. Funct. Mater. 2014 24 5482-5492.  15.  Y. Ping Q. Hu Gu. Tang J. Li*. FGFR-targeted gene delivery mediated by supramolecular assembly between β-cyclodextrin-crosslinked PEI and redox-sensitive PEG. Biomaterials 2013 34 6482-6494.16.  Y. Ping D. Wu  J. N. Kumar W. Cheng C. L. Lay Y. Liu*. Redox-responsive hyperbranched poly(amido amine)s with tertiary amino cores for gene delivery. Biomacromolecules 2013 14  2083–2094.17.  Y. Ping C. Liu Z. Zhang K. L. Liu J. Chen and J. Li*. Chitosan-graft-(PEI-β-cyclodextrin) copolymers and their supramolecular PEGylation for DNA and siRNA delivery. Biomaterials 2011 32 8328-8341.18.  Y. Ping C. D. Liu G. P. Tang J. S. Li J. Li W. T. Yang and F. J. Xu*. Functionalization of chitosan via atom transfer radical polymerization for gene delivery. Adv. Funct. Mater. 2010 20 3106-3116.19.  X. Lu# Y. Ping# F. J. Xu Z. H. Li Q. Q. Wang J. H. Chen W. T. Yang and G. P. Tang. Bifunctional conjugates comprising β-cyclodextrin polyethylenimine and 5-fluoro-2’-deoxyuridine for drug delivery and gene transfer. Bioconjug. Chem. 2010 21 1855–1863.20.  D. Chen# Y. Ping# G. P. Tang and J. Li. Polyethyleneimine-grafted poly(N-3-hydroxypropyl) aspartamide as a biodegradable gene vector for efficient gene transfection. Soft Matter 2010 6 955–964.